Literature DB >> 35094322

Real-Time Analysis of AKT Signaling Activities at Single-Cell Resolution Using Cyclic Peptide-Based Probes.

Fei Ji1, Siwen Wang1, Shiqun Shao1, Priyanka Sarkar1, Min Xue2.   

Abstract

Here we present a protocol for interrogating AKT signaling activities in living single cells, using a pair of cyclic peptide-based fluorescent probes. These probes are encapsulated in liposomes and delivered into cells, where they continuously report on AKT signaling activities through a Föster resonance energy transfer mechanism. We describe the use of a microwell chip to achieve single-cell resolution and demonstrate the procedure for on-chip immunostaining. Finally, we provide a method for data extraction, correction, and processing.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AKT singling; Cyclic peptides; Dynamics; Föster resonance energy transfer; Immunostaining; Single-cell analysis

Mesh:

Substances:

Year:  2022        PMID: 35094322     DOI: 10.1007/978-1-0716-1811-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.

Authors:  Sandra Misale; Rona Yaeger; Sebastijan Hobor; Elisa Scala; Manickam Janakiraman; David Liska; Emanuele Valtorta; Roberta Schiavo; Michela Buscarino; Giulia Siravegna; Katia Bencardino; Andrea Cercek; Chin-Tung Chen; Silvio Veronese; Carlo Zanon; Andrea Sartore-Bianchi; Marcello Gambacorta; Margherita Gallicchio; Efsevia Vakiani; Valentina Boscaro; Enzo Medico; Martin Weiser; Salvatore Siena; Federica Di Nicolantonio; David Solit; Alberto Bardelli
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

Review 2.  The PI3K/AKT Pathway as a Target for Cancer Treatment.

Authors:  Ingrid A Mayer; Carlos L Arteaga
Journal:  Annu Rev Med       Date:  2015-10-14       Impact factor: 13.739

Review 3.  Clinical implications of PTEN loss in prostate cancer.

Authors:  Tamara Jamaspishvili; David M Berman; Ashley E Ross; Howard I Scher; Angelo M De Marzo; Jeremy A Squire; Tamara L Lotan
Journal:  Nat Rev Urol       Date:  2018-02-20       Impact factor: 14.432

4.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

5.  Somatic mutations of PTEN in glioblastoma multiforme.

Authors:  S I Wang; J Puc; J Li; J N Bruce; P Cairns; D Sidransky; R Parsons
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

Review 6.  The role of autophagy in neurodegenerative disease.

Authors:  Ralph A Nixon
Journal:  Nat Med       Date:  2013-08-06       Impact factor: 53.440

7.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

Review 8.  Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.

Authors:  Brendan D Manning
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

Review 9.  Mutation of the PIK3CA oncogene in human cancers.

Authors:  B Karakas; K E Bachman; B H Park
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

Review 10.  Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.

Authors:  Paolo Bossi; Carlo Resteghini; Nicholas Paielli; Lisa Licitra; Silvana Pilotti; Federica Perrone
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.